Search Within

Neha Sanat Korde

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (82)
  2. Journal Article (26)
  3. Research Letter (4)
  4. Correspondence (2)
Groups
  1. Center for Hematologic Malignancies (114)
  2. Department of Medicine (114)
  3. Epidemiology and Biostatistics (114)
  4. Hematologic Malignancies, Division of (114)
  5. Myeloma (114)
  6. Survivorship Research (114)

More Groups

People
  1. Sham Mailankody (108)
  2. Alexander Lesokhin (107)
  3. Hani Hassoun (106)
  4. Sergio Giralt (97)
  5. Heather Landau (94)
  6. Malin Hultcrantz (94)

More People

Years
  1. 2025 (2)
  2. 2024 (15)
  3. 2023 (22)
  4. 2022 (22)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Blood (43)
  2. Clinical Lymphoma, Myeloma and Leukemia (26)
  3. Journal of Clinical Oncology (10)
  4. Blood Cancer Journal (6)
  5. Leukemia and Lymphoma (6)
  6. Biology of Blood and Marrow Transplantation (5)

More Publications

Publishers
  1. American Society of Hematology (45)
  2. Elsevier Inc. (32)
  3. American Society of Clinical Oncology (10)
  4. Nature Publishing Group (9)
  5. Taylor & Francis Group (6)
  6. Ferrata Storti Foundation (3)

More Publishers

Results (114)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depth of response and outcomes in patients with multiple myeloma undergoing autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Seier, K.; Devlin, S. M.; Chung, D. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Treatment outcomes in monoclonal immunoglobulin deposition disease (MIDD): A two center experience
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Flynn, J.; Devlin, S. M.; Jaffer-Sathick, I.; Rossi, A. C.; Salvatore, S. P.; Landau, H. J.; Lendvai, N.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Capture rate of the adaptive next generation sequencing VDJ assay in multiple myeloma
    Meeting Abstract

    Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Akhlaghi, T.; Jacob, A.; Patel, A.; Korde, N.; Mailankody, S.; Lendvai, N.; Lesokhin, A. M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
    Journal Article

    Lendvai, N.; Tsakos, I.; Devlin, S. M.; Schaffer, W. L.; Hassoun, H.; Lesokhin, A. M.; Landau, H.; Korde, N.; Mailankody, S.; Smith, E.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Journal Article

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Maloy, M.; Kenny, S.; Hassoun, H.; Korde, N. S.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Depth and timing of improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)
    Meeting Abstract

    Shah, G. L.; Assal, A.; Hsu, M.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of re-immunization with inactivated vaccines in multiple myeloma patients on lenalidomide maintenance following autologous hematopoietic stem cell transplantation (auto HCT)
    Meeting Abstract

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • MRD response-driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mailankody, S.; Smith, E. L.; Lendvai, N.; Hassoun, H.; Lesokhin, A.; Hultcrantz, M.; Chung, D. J.; Shah, G. L.; Koehne, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
    Journal Article

    Mailankody, S.; Kazandjian, D.; Korde, N.; Roschewski, M.; Manasanch, E.; Bhutani, M.; Tageja, N.; Kwok, M.; Zhang, Y.; Zingone, A.; more...
    Blood Advances (2017)

    Fulltext@MSK | Save
  • Galinpepimut-S, a WT1-targeting immuno-oncology treatment, induces specific, robust and durable immune responses (IRs) in patients (Pts) with high-risk (HR) multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Korde, N.; Mailankody, S.; Heather, L.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Sarlis, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save